Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +50.1% | +29.0% | 2 / 3 | +74.1% | -0.22 pp | -0.09 pp | +9.9% | 2.27 | 7.27 | 2.476 | +74,1% | 13,6 | +50,1% | 7.27 | 12.28 | −40,8% |
| Pts | 8 | 4 | 8 | 12 | 4 | 4 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 10.900 (close price on 2026-10-19)EPS (TTM): 1.500
Financial charts
1.Revenue & growth
VND bn2.476Q2/26
1.Revenue & growth
VND bn2.476Q2/26
2.Profit & growth
VND bn14,3Q2/26
3.Profit mix (Penman)
VND bn56,2Q2/26
4.Margins & cost structure
%2.7%Q2/26
5.Returns & cash cycle
% · days5.2%Q2/26
6.Earnings quality & cash
VND bn-51,1Q2/26
7.Asset structure
VND bn1.668Q2/26
8.Funding & debt health
VND bn · times1.668Q2/26
9.Revenue backlog
VND bn40,2Q2/26
10.Valuation
times · %7,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %524Q2/26
Adjusted EPS growth, latest quarter
58.3%
Average adjusted EPS growth, 3 quarters
31.7%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26